These data suggest that the ERK1/2 pathway activation might be implicated in NR4A1 nuclear export in DLBCLs, which has already been shown in lung cancer cells as well as human primary T- and kidney cells27–29. This evidence concerns the gene NR4A1 and lung carcinoma.